North American Journal of Medical Sciences · 2015 · 27 citations · 11 references
MedicineNeurosciencePharmacologyBehavioral PharmacologyNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepression PharmacotherapyAntidepressant EfficacyAntidepressant MedicationsAntidepressant ResponseBehavioral Pharmacology AssaysBlood-brain Barrier PermeabilityCalcium Influx MechanismsMechanisms Of Antidepressant ActionRodent Neuropharmacology
BACKGROUND: Flunarizine, a Ca(2+) channel blocker, crosses blood brain barrier (BBB), antagonizes calcium influx and interferes with neurotransmitter system. Flunarizine 20 mg/kg exhibited significant antidepressant activity in our previous study using forced swim test (FST) in mice, which was contradictory to the findings of other authors. Hence, the present study was designed to strengthen the results of our previous study, using the modified tail suspension test (TST) in rats. AIM: Aim of this study was to evaluate the antidepressant activity of flunarizine versus standard antidepressant drug fluoxetine in modified TST in rats. MATERIALS AND METHODS: The study approved by Institutional Animal Ethics Committee was conducted using 24 adult albino rats (n = 6 in each group). Antidepressant effect of normal saline (0.1 ml/100 g), fluoxetine (10 mg/kg, intraperitoneally (ip)), and flunarizine (2 and 10 mg/kg, ip) was evaluated by using modified TST in rats. Thirty minutes after administration of all test drugs the duration of immobility was recorded for a period of 5 min in all rats by using modified TST. The data was analyzed by Student's t-test and one-way analysis of variance (ANOVA) and P < 0.05 was considered significant. RESULTS: Mean duration of immobility was significantly reduced in fluoxetine and flunarizine (10 mg/kg, ip) group as compared to the normal saline, that is, 160.33, 175.17, and 226.83 s, respectively (P < 0.05). Decrease in immobility with flunarizine (10 mg/kg, ip) was statistically significant compared with normal saline, but was not found to be significant when compared to fluoxetine (P > 0.05). Also, currently used human dose of flunarizine when extrapolated to rats (i. e., 2 mg/kg, ip) failed to show significant antidepressant effect in modified TST in rats. CONCLUSION: The results of the present study indicate antidepressant-like activity of flunarizine.
11
The tail suspension test: A new method for screening antidepressants in mice
Lucien Stéru, R Chermat, Bernard Thierry et al. · Psychopharmacology · 1985 · 3.5K citations
Roser Cort�s, Porntip Supavilai, Manfred Karobath et al. · Journal of Neural Transmission · 1984 · 148 citations
Mustapha Riad · Journal of Neuroscience · 2004 · 142 citations · Full text
Medicine, Neuroscience, Pharmacology +17
The tail suspension test: Ethical considerations
Bernard Thierry, L. St�ru, Pierre Simon et al. · Psychopharmacology · 1986 · 140 citations
Adaptation of the tail suspension test to the rat.
R Chermat, Bernard Thierry, J.A. Micó et al. · PubMed · 1987 · 90 citations